title: Duloxetine-induced cutaneous adverse reaction.
authors.forename: Panagiotis
authors.initials: P
authors.lastname: Oulis
authors.forename: Vasilios G
authors.initials: VG
authors.lastname: Masdrakis
authors.forename: Nikolaos A
authors.initials: NA
authors.lastname: Karakatsanis
authors.forename: Evangelos
authors.initials: E
authors.lastname: Karapoulios
authors.forename: Anastasios V
authors.initials: AV
authors.lastname: Kouzoupis
authors.forename: Constantin R
authors.initials: CR
authors.lastname: Soldatos
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000188:drug therapy; D000068736:Duloxetine Hydrochloride; D005076:Exanthema / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011537:Pruritus / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D013876:Thiophenes / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D018759:Adrenergic Uptake Inhibitors; D000068736:Duloxetine Hydrochloride; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes